tokens: The protease inhibitors N alpha-tosylphenylalanyl chloromethyl ketone ( TPCK ) and N alpha-tosyl-L-lysine chloromethyl ketone ( TLCK ) block activation of NF-kappa B/Rel proteins by preventing degradation of I kappa B alpha .